How do bacteria - harmless ones living in our bodies, or those that cause disease - organize their activities? A new study, combining powerful genomic-scale microscopy with a technical innovation, ...

While some of the initial zeal around localized vaccine production in Africa has waned since the height of the COVID-19 pandemic, efforts to bolster the continent’s immunization autonomy—especially | ...

During translation, ribosomes can pause on the nucleic acid. Researchers showed that collisions from incoming proteins get ...

A research team has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.

Researchers uncover key mechanisms in gene regulation that may lead to better design of RNA-based medicines.

Russell Broadbent and a group comprising scientists, health professionals, lawyers, and academics, wrote to the Prime ...

Scientists from the Cancer Dependency Map (DepMap) at the Broad Institute of MIT and Harvard and Columbia University have ...

Africa’s EVA Pharma, France’s DNA Script, and Belgium’s Quantoom Biosciences have signed a Memorandum of Understanding which ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities ...

Akribion Therapeutics emerges from stealth with €8 million in seed funding to develop a novel cancer RNA-guided approach ...

Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health and more research on other diseases.

Design Therapeutics' GeneTAC platform is revolutionizing genetic disease treatment with small molecules and promising results ...